To address such pressing health challenges in the world as HIV/AIDS and malnutrition in developing nations, Cornell has established an innovative Global Health Program, a collaborative effort between Cornell's Ithaca campus and Weill Cornell Medical College in New York City. (Feb. 9, 2007)
Cornell President David Skorton congratulates the staff and academic leadership of NewYork-Presbyterian Hospital for its sixth-place ranking in the U.S. News and World Report 'America's Best Hospitals' survey.
Surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center are the first in the New York City metropolitan area to successfully implant into the brain arteries a new stent specifically designed to treat high-risk stroke patients.
An electrocardiogram is an effective tool for detecting risk of congestive heart failure (CHF) in patients with hypertension, according to a new study by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Many patients with AIDS in Haiti who received antiretroviral therapy had a one-year survival of 87 percent for adults and 98 percent for children, triple the 30 percent one-year survival of Haitian patients without the therapy, according to a study.
'You are the unsung heroes and heroines of our society,' media star Katie Couric, co-anchor of NBC's 'Today' show, said in a moving speech to doctors and other health-care professionals gathered to discuss crucial updates and issues in gastrointestinal cancers.
A new study using an old, misunderstood technique -- hypnotic suggestion -- finds the brain can override responses experts have long assumed to be ingrained and automatic, such as reading. (Aug. 1, 2005)
Revisiting a hallowed ritual for doctors, a committee within the Weill Cornell Medical College convened this spring to craft an updated Hippocratic Oath, one that responds to the state of modern medicine. Written in ancient Greece, the oath expresses principles still fundamental to the practice of medicine today. (June 22, 2005)
Vaccines that train the immune system to seek out and destroy malignant cells are at the cutting edge of cancer treatment. Now, joint research – conducted by researchers at Weill Medical Cornell and at the Ludwig Institute for Cancer Research Memorial Sloan-Kettering Cancer Center Branch in New York – has pinpointed two proteins that seem ideal targets for a vaccine against multiple myeloma.
